Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ronchi

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Pituitary|October 24, 2008
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentalomaE Verrua, C L Ronchi, E Ferrante, et al.
Journal of Endocrinological Investigation|February 1, 2025
ccfDNA analysis for the classification of adrenocortical adenomasMengjie Xu, David S Tourigny, Juliane Lippert, et al.
Clinical Endocrinology|May 8, 2010
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotypeLaura Montefusco, Marcello Filopanti, Cristina L Ronchi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 9, 2009
Evaluation of GH-IGF-I axis in adult patients with coeliac diseaseE Ferrante, C Giavoli, L Elli, et al.
Plos One|August 22, 2014
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinomaCristina L Ronchi, Silviu Sbiera, Marco Volante, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2012
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiencyClaudia Giavoli, Eriselda Profka, Elisa Verrua, et al.
Annals of Surgical Oncology|November 17, 2018
Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical TreatmentJoachim Reibetanz, Britta Rinn, Andreas S Kunz, et al.
Endocrine Connections|November 22, 2023
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinomaEmily Warmington, Gabrielle Smith, Vasileios Chortis, et al.
Clinical Endocrinology|June 9, 2007
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal studyC L Ronchi, M Boschetti, E C Degli Uberti, et al.
European Journal of Endocrinology|March 7, 2024
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinomaJuliane Lippert, Gabrielle Smith, Silke Appenzeller, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Pituitary|October 24, 2008
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentalomaE Verrua, C L Ronchi, E Ferrante, et al.
Journal of Endocrinological Investigation|February 1, 2025
ccfDNA analysis for the classification of adrenocortical adenomasMengjie Xu, David S Tourigny, Juliane Lippert, et al.
Clinical Endocrinology|May 8, 2010
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotypeLaura Montefusco, Marcello Filopanti, Cristina L Ronchi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 9, 2009
Evaluation of GH-IGF-I axis in adult patients with coeliac diseaseE Ferrante, C Giavoli, L Elli, et al.
Plos One|August 22, 2014
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinomaCristina L Ronchi, Silviu Sbiera, Marco Volante, et al.
The Journal of Clinical Endocrinology and Metabolism|August 21, 2012
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiencyClaudia Giavoli, Eriselda Profka, Elisa Verrua, et al.
Annals of Surgical Oncology|November 17, 2018
Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical TreatmentJoachim Reibetanz, Britta Rinn, Andreas S Kunz, et al.
Endocrine Connections|November 22, 2023
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinomaEmily Warmington, Gabrielle Smith, Vasileios Chortis, et al.
Clinical Endocrinology|June 9, 2007
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal studyC L Ronchi, M Boschetti, E C Degli Uberti, et al.
European Journal of Endocrinology|March 7, 2024
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinomaJuliane Lippert, Gabrielle Smith, Silke Appenzeller, et al.
Pageof 19